Louis M. Staudt

National Institutes of Health, National Cancer Institute

9609 Medical Center Drive

Bethesda, MD 20892

United States

SCHOLARLY PAPERS

1

DOWNLOADS

12

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (1)

1.

Genome-Wide Screens Identify Lineage- and Tumor-Specific Genes Modulating MHC-I and MHC-II Immunosurveillance in Human Lymphomas

Number of pages: 39 Posted: 14 May 2020
National Institutes of Health, National Institute of Allergy and Infectious Diseases, Laboratory of Viral Diseases, National Institutes of Health, National Cancer Institute, University of Pennsylvania, National Institutes of Health, National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Laboratory of Viral Diseases, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Laboratory of Viral Diseases, National Institutes of Health, National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Laboratory of Viral Diseases, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Laboratory of Viral Diseases, National Institutes of Health, National Cancer Institute, National Institutes of Health, National Cancer Institute, National Institutes of Health, National Center for Advancing Translational Sciences, Division of Preclinical Innovation, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Laboratory of Viral Diseases, National Institutes of Health, National Cancer Institute and National Institutes of Health - Laboratory of Viral Diseases
Downloads 12 (620,664)

Abstract:

Loading...

diffuse large B-cell lymphoma, antigen presentation, MHC class I, MHC-I, MHC class II, Immunotherapy, immunoevasion, EZH2, SUGT1, thymidylate synthase